Wein, WIE launched a monoclonal antibody infusion COVID-19 treatment pilot for high-risk patients

Wein, WIE monoclonal antibody COVID-19 treatment pilot

The City of Vienna's Health Service launched a COVID therapy pilot using monoclonal antibodies for high-risk patients at the Klinik Favoriten of the Vienna Health Association. The pilot involves administering the approved active ingredient Sotrovimab, brand name Xevudy®, to significantly reduce the risk of hospitalization for high-risk COVID patients. During the pilot, patient eligibility is determined on the basis of risk factors and individual medical advice.

W(

Wien (Vienna), WIE

City in Wien (Vienna)

Austria